FDA Approved: ZONEGRAN — Supplemental Application (Advanz Pharma (US) Corp.)

View source ↗

Summary

FDA approved a supplemental application for ZONEGRAN (zonisamide) submitted by Advanz Pharma (US) Corp. under NDA 020789.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial Seizures

Drugs mentioned

• Zonegran (zonisamide)

Snippet

SUPPL AP for ZONEGRAN (ZONISAMIDE)